ConCallIQ
Go Pro
APOLLOTYRE Diversified 15 Nov 2025

Apollo Tyres Limited — Q2 FY26

Apollo Tyres reported a solid Q2 FY26 with consolidated revenue of INR 68.3 billion (+6% YoY) and EBITDA margin of 14.9% (+130 bps YoY), driven by strong India performance and recovery in exports.

bullish high
Compare with...
Revenue ₹6,830 Cr +6%
EBITDA ₹1,020 Cr
PAT
EBITDA Margin 14.9% +130bps
Duration
Read Time 1 min read

Financial stats pending filing verification

2-Minute Summary

✦ AI-Generated from Full Transcript

Apollo Tyres reported a solid Q2 FY26 with consolidated revenue of INR 68.3 billion (+6% YoY) and EBITDA margin of 14.9% (+130 bps YoY), driven by strong India performance and recovery in exports. India revenue grew 6% to INR 47.1 billion with EBITDA margin of 15.3%, aided by GST rationalization benefits and volume growth in replacement and OEM segments. Europe revenue grew 4% YoY to EUR 177 million, though demand remains challenging. Management expects healthy demand momentum in H2, with October showing strong growth. Raw material costs are expected to remain range-bound. Risks include competitive intensity from new entrants and uncertain European demand recovery.

Risks4 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

New entrant competition in India

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

India Volume Growth 4%
+4% YoY

Overall volume growth in India for Q2 FY26, driven by farm and two/three-wheeler segments.

Europe UHP Mix 49%
+3pp YoY

Ultra-high performance tire mix in Europe increased to 49% from 46% last year, supporting premiumization.

India TBR Market Share 29%
flat

Estimated market share in India TBR replacement segment, with share loss arrested.

India PCR Market Share 20%
flat

Estimated industry-leading market share in India PCR replacement segment.

What Changed vs Last Quarter

Comparing Q2 FY26 vs Q3 FY25
4 new guidance4 dropped4 new risk3 risk resolved
NEW
H2 revenue growth to sustain or improve

Management expects Q3 revenue growth to be at least at Q2 levels, driven by GST benefits and brand investments.

NEW
EBITDA margin to sustain or improve in H2

Profitability expected to remain at current levels or improve, supported by stable raw material costs and operating leverage.

NEW
India replacement demand to grow mid-to-high single digits

Replacement demand expected to improve from current low levels to mid-to-high single digit growth.

NEW
Enschede closure by end June 2026

Production closure at Enschede plant expected by end June 2026, with payback period of about two years on EUR 55 million cash costs.

DROPPED
Q4 replacement demand momentum to continue

Management expects healthy replacement demand momentum in Q4, with signs of further pickup beyond current levels.

DROPPED
Raw material costs flattish in Q4 vs Q3

RM costs expected to be range-bound in Q4, around similar levels as Q3, indicating plateauing.

DROPPED
No price hikes planned in near term

Given market situation, no price increase is planned in the near term; will continue to assess.

DROPPED
Capex to increase next year for PCR capacity

Next year's capex will increase above maintenance level (~₹700-750 cr) by about ₹800 cr for PCR capacity expansion in India and Europe.

NEW RISK
New entrant competition in India

A financially strong new player is entering PCR and TBR segments, potentially increasing competitive intensity and pricing pressure.

NEW RISK
European demand recovery uncertainty

European market remains challenging with low single-digit growth expected; recovery is not yet assured.

NEW RISK
Raw material cost volatility

While raw materials are currently stable, any upturn could pressure margins, especially given competitive pricing dynamics.

NEW RISK
OEM share loss in PCR

Apollo lost ground in PCR OEM shares due to not bidding for certain unprofitable businesses, which may impact future volumes.

RISK GONE
Competitive intensity limiting price hikes

Management cited competitive intensity as reason for not planning price hikes despite margin pressure.

RISK GONE
Export weakness due to freight cost fluctuations

Exports were flattish due to weak demand in certain markets and high logistics costs, with peers outperforming.

RISK GONE
Gross margin pressure from high-cost inventory

India gross margin contracted ~300bps QoQ partly due to consumption of high-cost inventory; normalization expected but uncertain.

Fast read

Guidance and risk preview

Top guidance H2 revenue growth to sustain or improve

Management expects Q3 revenue growth to be at least at Q2 levels, driven by GST benefits and brand investments.

Top risk New entrant competition in India

A financially strong new player is entering PCR and TBR segments, potentially increasing competitive intensity and pricing pressure.

View Risks →